Roper Technologies, Inc.
http://www.ropertech.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Roper Technologies, Inc.
Stock Watch: Lilly’s Emgality Trod A Well-Beaten Path To Clinical Failure
The outcome of any clinical study is uncertain but the choice of active comparator and sometimes even the placebo arm can magnify unpredictability. Emgality’s recent head-to-head failure in migraine is just the latest in a long list of casualties.
PBM Integration: Economists Outline Benefits Of Mergers In Senate Hearing
Recent mergers between PBMs and insurers should address one long-term strategic objective of pharma – the recognition by payors of the value of biopharmaceutical products in relation to other medical costs.
Medicare Part D ‘Enhanced MTM Model’ Saves $325m In First Year
US Centers for Medicare and Medicaid Services announces first-year results from its medication therapy management model, intended to optimize prescription drug use among Medicare beneficiaries.
WellCare To Triple Medicare Part D Membership With Purchase Of Aetna Plans
Divestiture prevents CVS from gaining even more dominance in the stand-alone Medicare Part D sector with its acquisition of Aetna, assuming the transaction is cleared by the government.
Company Information
- Industry
- Diversified
- Other Names / Subsidiaries
-
- Verathon, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice